American Diabetes Association.Diagnosis and classification of diabetes mellitus.Diabetes care2005; 28(Suppl 1): S37–42.
2.
FangW., YangX., KothariJ., KhandelwalM., NaimarkD., JassalS.V.Patient and technique survival of diabetics on peritoneal dialysis: one-center's experience and review of the literature.Clin Nephrol2008; 69: 193–200.
3.
PortolésJ., CorcheteE., López–SánchezP., CoronelF., OcañaJ., OrtizA on behalf of Miembros del GCDP. Patients on peritoneal dialysis with type 2 diabetes present poorer progress than non-diabetics at the expense of their cardiovascular comorbidity [Spanish].Nefrología2009; 29: 336–42.
4.
CoronelF., CigarránS., HerreroJ.A.Morbidity and mortality in diabetic patients on peritoneal dialysis. Twenty-five years of experience at a single centre [Spanish].Nefrología2010; 30: 626–32.
5.
OreopoulosD.G.Duration of peritoneal dialysis—ten years and more [Editorial].Perit Dial Bull1984; 4: 61–2.
6.
CoronelF., CigarranS., HerreroJ.A.Early initiation of peritoneal dialysis in diabetic patients.Scand J Urol Nephrol2009; 3: 148–53.
7.
BerlangaJ.R., MarrónB., ReyeroA., CarameloC., OrtizA.Peritoneal dialysis retardation of progression of advanced renal failure.Perit Dial Int2002; 22: 239–42.
8.
PaniaguaR., VenturaM.D., Avila–DíazM., CisnerosA., Vicenté–MartínezM., FurlongM.D.Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients.Perit Dial Int2009; 29: 422–32.
9.
TorresA., LorenzoV., HernándezD., RodríguezJ.C., ConcepciónM.T., RodríguezA.P.Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH.Kidney Int1995; 47: 1434–42.
10.
DimkovicN.B., BargmanJ., VasS., OreopoulosD.G.Normal or low initial PTH levels are not a predictor of morbidity/ mortality in patients undergoing chronic peritoneal dialysis.Perit Dial Int2002; 22: 204–10.
